Cranio-lenticulo-sutural dysplasia associated with defects in collagen secretion.

Section of Genetics, Department of Pediatrics, University of California Davis Medical Center, Sacramento, CA, USA.
Clinical Genetics (Impact Factor: 3.65). 09/2010; 80(2):169-76. DOI: 10.1111/j.1399-0004.2010.01550.x
Source: PubMed

ABSTRACT Cranio-lenticulo-sutural dysplasia (CLSD) is a rare autosomal recessive syndrome manifesting with large and late-closing fontanels and calvarial hypomineralization, Y-shaped cataracts, skeletal defects, and hypertelorism and other facial dysmorphisms. The CLSD locus was mapped to chromosome 14q13-q21 and a homozygous SEC23A F382L missense mutation was identified in the original family. Skin fibroblasts from these patients exhibit features of a secretion defect with marked distension of the endoplasmic reticulum (ER), consistent with SEC23A function in protein export from the ER. We report an unrelated family where a male proband presented with clinical features of CLSD. A heterozygous missense M702V mutation in a highly conserved residue of SEC23A was inherited from the clinically unaffected father, but no maternal SEC23A mutation was identified. Cultured skin fibroblasts from this new patient showed a severe secretion defect of collagen and enlarged ER, confirming aberrant protein export from the ER. Milder collagen secretion defects and ER distention were present in paternal fibroblasts, indicating that an additional mutation(s) is present in the proband. Our data suggest that defective ER export is the cause of CLSD and genetic element(s) besides SEC23A may influence its presentation.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Glycans are highly diverse carbohydrate moieties that have been selected in evolution to convey dynamic structural and functional properties to the macromolecules to which they are attached. For this reason, correct glycan synthesis is essential for various developmental and physiological processes, particularly in multicellular organisms that use them as communication pathways. The disruption of glycan synthesis frequently results in multisystemic disease with neurological involvement. Congenital disorders of glycosylation (CDGs) have been and will likely remain a rapidly growing group of genetic human diseases that involve different defects in the synthesis or remodelling of N-and O-linked glycans as well as defects in glycosphingolipid and glycosylphosphatidylinositol (GPI) anchor glycosylation. The molecular and clinical characterization of CDGs has enormously contributed to understanding the physiologic roles of the glycosylation machinery and its interaction with other cellular machineries. More than 50 different types of defects have been described and although the first type was described in 1984, CDGs remain widely under-diagnosed or misdiagnosed. This review describes the genetic and biochemical basis of CDGs, as well as the clinical phenotypes and current methods to diagnose them that are ultimately required to establish corrective treatments that are also discussed.
    Glycans: Biochemistry, Characterization and Applications, Edited by Mora-Montes H, 05/2012: chapter Congenital Disorders of Glycosylation: pages 59-82; Nova Science., ISBN: 1619425416
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cellular life depends on protein transport and membrane traffic. In multicellular organisms, membrane traffic is required for extracellular matrix deposition, cell adhesion, growth factor release, and receptor signaling, which are collectively required to integrate the development and physiology of tissues and organs. Understanding the regulatory mechanisms that govern cargo and membrane flow presents a prime challenge in cell biology. Extracellular matrix (ECM) secretion remains poorly understood, although given its essential roles in the regulation of cell migration, differentiation, and survival, ECM secretion mechanisms are likely to be tightly controlled. Recent studies in vertebrate model systems, from fishes to mammals and in human patients, have revealed complex and diverse loss-of-function phenotypes associated with mutations in components of the secretory machinery. A broad spectrum of diseases from skeletal and cardiovascular to neurological deficits have been linked to ECM trafficking. These discoveries have directly challenged the prevailing view of secretion as an essential but monolithic process. Here, we will discuss the latest findings on mechanisms of ECM trafficking in vertebrates.
    The international journal of biochemistry & cell biology 12/2013; · 4.89 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Transport protein particle (TRAPP) represents a series of related protein complexes that function in specific stages of inter-organelle traffic. They share a core of subunits that can activate the GTPase Rab1 through a guanine nucleotide exchange factor (GEF) activity and are distinguished by "accessory" subunits giving each complex its distinct function. The subunits are ubiquitously expressed and, thus, mutations in TRAPP subunits would be expected to be embryonic lethal. However, since its discovery, a number of subunits have been found to be mutated in several diverse human disorders suggesting that some of these subunits may have cell- or tissue-specific functions. Here we review the current state of knowledge with respect to TRAPP subunit mutations in human disease. We suggest ideas to explain their tissue-specific phenotypes and present avenues for future investigation.
    Traffic 06/2014; · 4.71 Impact Factor

Full-text (2 Sources)

Available from
Oct 28, 2014